UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000016782
Receipt No. R000019475
Scientific Title An exploratory study of treatment sensitivity and prognostic factors in a Phase III, randomized, controlled study comparing the efficacy and safety of mFOLFOX6 + bevacizumab therapy vs. mFOLFOX6 + panitumumab therapy in patients with chemotherapy-naïve wild-type RAS(KRAS/NRAS) unresectable advanced or recurrent colorectal cancer
Date of disclosure of the study information 2015/03/23
Last modified on 2017/06/14 19:06:42

No. Disposal Last modified on Item of update
1 Insert 2015/03/11 18:58:19
2 Update 2015/03/24 10:22:51 Last name of contact person
Last name of contact person
Division name
Address
Name of person sending information
Name of person sending information
3 Update 2015/03/24 10:24:27 Email
4 Update 2015/06/16 12:10:19 Recruitment status
5 Update 2015/10/15 19:17:36 Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
Org. issuing International ID_2
6 Update 2016/09/12 09:04:56 Name of primary sponsor
Organization
7 Update 2017/06/14 19:06:42 Recruitment status


Contact us.